IndomethacinThird Party Manufacturing in India

Indomethacin works by inhibiting the activity of cyclooxygenase-1 and cyclooxygenase-2 enzymes, which catalyse the rate-limiting step in the conversion of arachidonic acid to prostaglandin H₂, the common precursor of all prostanoids including prostaglandins, prostacyclin, and thromboxanes. By competitively and reversibly binding to the active site of both COX isoforms, Indomethacin prevents the formation of prostaglandins that mediate inflammation, pain, and fever. The drug is one of the most potent NSAIDs available and demonstrates particularly strong inhibition of COX-1, which accounts for its pronounced anti-inflammatory efficacy as well as its gastrointestinal side effect profile. Beyond COX inhibition, Indomethacin also inhibits the migration of leucocytes into inflamed tissues, reduces the production of free radicals and superoxide anions by activated neutrophils, and may interfere with the activation and aggregation of platelets through thromboxane A₂ suppression. The drug additionally inhibits the activation of nuclear factor kappa B, a transcription factor that regulates the expression of pro-inflammatory cytokines including interleukin-1, interleukin-6, and tumour necrosis factor-alpha. This broad spectrum of anti-inflammatory actions makes Indomethacin particularly effective in conditions characterised by intense inflammation, such as acute gouty arthritis and ankylosing spondylitis, where prostaglandin production is dramatically elevated.

Indomethacin is a potent non-steroidal anti-inflammatory drug prescribed for the management of moderate to severe inflammatory conditions that require a high degree of anti-inflammatory efficacy. It is particularly valued in rheumatology and orthopaedic medicine for conditions where rapid relief of inflammation is essential. The drug is available in multiple dosage strengths of 25mg, 50mg, and 75mg tablets, allowing for flexible dose titration based on the severity of the condition and individual patient response.

Therapeutic Uses

• Rheumatoid Arthritis: Indomethacin is indicated for the relief of pain, swelling, and morning stiffness in patients with active rheumatoid arthritis, including juvenile idiopathic arthritis, providing significant improvement in joint function and mobility.
• Osteoarthritis: The drug is used to manage pain and inflammation in large weight-bearing joints such as the knees and hips, helping patients maintain daily activity levels and delaying functional decline.
• Ankylosing Spondylitis: Indomethacin is one of the first-line agents for this chronic inflammatory spinal condition, effectively reducing spinal pain, stiffness, and enthesitis.
• Acute Gouty Arthritis: The drug provides rapid and potent relief of the intense inflammation and pain associated with acute gout flares, typically showing improvement within hours of administration.
• Acute Musculoskeletal Disorders: Indomethacin is used for bursitis, tendinitis, capsulitis, and acute low back pain where other analgesics are insufficient.

Why Manufacturers Choose Indomethacin

Indomethacin is a well-established NSAID with decades of clinical use, a predictable safety profile, and consistent demand across rheumatology, orthopaedic, and primary care settings. Indian pharmaceutical manufacturers produce Indomethacin across three strengths, making it a versatile product for PCD franchise distribution. The molecule is also manufactured in sustained-release formulations and topical gels, expanding its market reach. Its inclusion in hospital formularies and essential medicines lists across India, Africa, and Southeast Asia ensures predictable offtake, and the established API supply chain within India makes it a cost-effective molecule for third party manufacturing.